scispace - formally typeset
Search or ask a question

Showing papers by "Lawrence S. Melvin published in 1981"


Journal ArticleDOI
Lawrence S. Melvin1
TL;DR: In this article, the high yield conversion of phenols into diethyl 2-hydroxyphenylphosphonates via base catalyzed rearrangement of Diethyl phenyl phosphates has been achieved.

88 citations


Journal ArticleDOI
TL;DR: Modifications of the side chain, the phenolic moiety, and structures that lack the benzopyran functionality present in THC and HHC are examined, resulting in a unique family of benzoquinolines with potent analgetic activity.
Abstract: Based on the hypothesis that analgetic activity is a dissociable feature of the cannabinoid molecule, we examined modifications of the side chain, the phenolic moiety, and, most significantly, structures that lack the benzopyran functionality present in THC and (--)-9-nor-9 beta-hydroxyhexahydrocannabinol (HHC). A new grouping, the 1-methyl-4-phenylbutyloxy C-3 side chain, elaborates a unique lipopholic region. Replacement of the phenol substituent produced several derivatives which retain analgetic activity in the codeine potency range. Introduction of a weakly basic nitrogen at C-5 and deletion of the axial methyl group in the B ring, two structural changes forbidden by traditional cannabinoid SAR, resulted in a unique family of benzoquinolines with potent analgetic activity. The prototype of this series, levonantradol, exhibits potent and stereospecific analgetic and antiemetic activity.

62 citations


Patent
28 Jul 1981
TL;DR: In this article, the authors describe the preparation of CNS agents, antidiarrheals and antiemetics, and the intermediates therefor are described, as well as their use as CNS agents.
Abstract: Compounds having the formula ##STR1## R 1 is hydrogen, benzyl or an ester moiety; Y is --CH(R 2 ")CH(R 2 )-- or--CH(R 3 )CH 2 --; R 2 " is hydrogen or methyl; R 2 is OH or X-substituted (C 1-6 )alkyl; R 3 is OH, cyano or X-substituted (C 1-3 ) alkyl; X is --OR 6 , --SR 6 , --S(O)R 6 , --S(O) 2 R 6 , --NR 6 R 7 , --COOR 7 , --CONR 7 R 8 or oxo; with the proviso that when X is --NR 6 R 7 , --COOR 7 or --CONR 7 R 8 , said group is located on the terminal carbon atom of R 2 or R 3 ; R 6 is hydrogen, (C 1-6 )alkyl or acetyl; each of R 7 and R 8 is hydrogen or (C 1-6 )alkyl; s is an integer of 1 or 2; with the proviso that when R 6 is acetyl, R 7 is hydrogen and X is other than S(O)R 6 or S(O) 2 R 6 ; Z--W is alkyl, phenylalkyl or pyridylalkyl which can have an oxygen atom as part of the alkyl chain, and their use as CNS agents, antidiarrheals and antiemetics. Processes for their preparation and intermediates therefor are described.

23 citations


Patent
27 Jul 1981
TL;DR: In this paper, the authors describe cycloalkanones, cyclo-alkanols, and unsaturated analogs thereof, each of which has at the 3-position a 2-hydroxy-4-substituted phenyl group wherein the 4-position substituent is alkyl which can have an oxygen atom as part of the chain, or aralkyl, which can also have an atom in the alkyls chain, their use for pharmacological and medicinal purposes.
Abstract: Cycloalkanones, cycloalkanols and unsaturated analogs thereof, each of which has at the 3-position a 2-hydroxy-4-substituted phenyl group wherein the 4-position substituent is alkyl which can have an oxygen atom as part of the chain, or aralkyl which can have an oxygen atom as part of the alkyl chain, their use for pharmacological and medicinal purposes, intermediates therefor and processes for their preparation.

15 citations


Patent
02 Dec 1981
TL;DR: In this paper, the authors describe the preparation and inter-mediation of CNS agents, antidiarrheals and anti-emetics, and their use as CNS agents.
Abstract: Compounds having the formula wherein is = 0, , , , or ; is =0, , =CH2, , , , , or ; R1 is hydrogen, benzyl or alkanoyl, X is C2-4 alkylene; and Z-W is alkyl, phenylalkyl or pyridylalkyl which can have an oxygen atom as part of the alkyl chain and their use as CNS agents, antidiarrheals and anti-emetics. Processes for their preparation and inter-mediates therefor are described.

5 citations


Journal Article
TL;DR: These studies demonstrate that the C-3 side chain of HHC can be modified in a structure-dependent fashion to yield potent, nonopioid analgetics.
Abstract: Based on the report of morphine-like analgetic activity of 9-nor-9 beta-hydroxyhexahydrocannabinol (HHC), we undertook a study of structural modifications of the C-3 side chain of HHC to optimize the analgetic activity. We ultimately examined four distinct classes of side chains: (1) alkyl (la-lc), (2) arylalkyl (ld-lh), (3) alkoxy (li-lj) and (4) arylalkyloxy (lk-lo). Three of these derivatives (lb, lf, ll) possessed analgetic activity 10X morphine. These studies demonstrate that the C-3 side chain of HHC can be modified in a structure-dependent fashion to yield potent, nonopioid analgetics. In addition, the effect of the 1 methyl-4-phenylbutyloxy side chain is unique among the side chains examined.

2 citations